Ranbaxy takes precautions and recalls a medicine

Ranbaxy Pharmaceuticals today announced recalling batches of its deworming medication Wormstop Suspension in South Africa.
The company announced the recall in the national daily Business Report.
“The reason for the recall is that the suspension does not flow easily from the bottles as it normally would when poured,” it said.

“The suspension has thickened and is not flowing correctly. This may, during the administration, result in either under dosing which may lead to re indentation, or overdosing which may lead to reversible side effects such as vomiting, fever and diarrhoea,” the company said, urging any person in possession of the product from two batch numbers listed to return it for refund or replacement.
No information was given on how Ranbaxy had discovered the fault in the product or how many bottles were in circulation.

Ranbaxy Laboratories has a manufacturing facility near Johannesburg, where it initially partnered with South African company Be-Tabs Pharmaceuticals in September 2010.

Ranbaxy is a subsidiary of Sun Pharma, the largest pharmaceutical manufacturer in India.